TMEM63A, associated with hypomyelinating leukodystrophies, is an evolutionarily conserved regulator of myelination

J Julia Halford (Vollum Institute, Oregon Health & Science University) A Amanda J. Senatore (Vollum Institute, Oregon Health & Science University) S Sage Berryman (Vollum Institute, Oregon Health & Science University) A Antonio Muñoz (Vollum Institute, Oregon Health & Science University) D Destinee Semidey (Vollum Institute, Oregon Health & Science University) R Ryan A. Doan (Vollum Institute, Oregon Health & Science University) A Adam M. Coombs (Vollum Institute, Oregon Health & Science University) B Brandon Noimany (Vollum Institute, Oregon Health & Science University) K Katie Emberley (Jungers Center for Neurosciences Research, Oregon Health & Science University) B Ben Emery K Kelly R. Monk S Swetha E. Murthy (Vollum Institute, Oregon Health & Science University)

Abstract

Infantile hypomyelinating leukodystrophy 19 (HLD19) is a rare genetic disorder where patients exhibit reduced myelin in central nervous system (CNS) white matter tracts and present with varied neurological symptoms. The causative gene TMEM63A encodes a mechanosensitive ion channel whose role in myelination is largely unexplored. Our study shows that TMEM63A is a major regulator of oligodendrocyte (OL)-dependent myelination in the CNS. In mouse and zebrafish, Tmem63a inactivation led to early deficits in myelination, recapitulating the HLD19 phenotype. OL-specific conditional mouse knockouts of Tmem63a exhibited transient reductions in myelin, indicating that TMEM63A regulates myelination cell-autonomously. We show that TMEM63A is present at the plasma membrane and on lysosomes and modulates myelin production in the presence of mechanical cues. Intriguingly, HLD19-associated TMEM63A variants from patients blocked trafficking to cell membrane. Together, our results reveal an ancient role for TMEM63A in fundamental aspects of myelination in vivo and highlight two exciting models for the development of treatments for devastating hypomyelinating leukodystrophies.

Article Details

Volume / Issue Vol. 122, Issue 30
Published July 29, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (12)

J

Julia Halford

Vollum Institute, Oregon Health & Science University

A

Amanda J. Senatore

Vollum Institute, Oregon Health & Science University

S

Sage Berryman

Vollum Institute, Oregon Health & Science University

A

Antonio Muñoz

Vollum Institute, Oregon Health & Science University

D

Destinee Semidey

Vollum Institute, Oregon Health & Science University

R

Ryan A. Doan

Vollum Institute, Oregon Health & Science University

A

Adam M. Coombs

Vollum Institute, Oregon Health & Science University

B

Brandon Noimany

Vollum Institute, Oregon Health & Science University

K

Katie Emberley

Jungers Center for Neurosciences Research, Oregon Health & Science University

B

Ben Emery

K

Kelly R. Monk

S

Swetha E. Murthy

Vollum Institute, Oregon Health & Science University